9,656
Total Claims
$1.3M
Drug Cost
1,663
Beneficiaries
$801
Cost/Patient
Peer Comparison vs. 109,535 Physician Assistant providers
+11%
Cost per patient vs peers
$801 vs $719 avg
+106%
Brand preference vs peers
13.7% vs 6.7% avg
Brand vs Generic
86% generic
Brand: 1,320 claims · $1.2M
Generic: 8,336 claims · $147K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 719 | $668K |
| Rivaroxaban | 173 | $165K |
| Mavacamten | 16 | $134K |
| Sacubitril/Valsartan | 53 | $67K |
| Ticagrelor | 49 | $40K |
| Dapagliflozin Propanediol | 28 | $27K |
| Empagliflozin | 34 | $25K |
| Dronedarone Hcl | 15 | $15K |
| Metoprolol Succinate | 657 | $15K |
| Evolocumab | 22 | $13K |
| Ranolazine | 81 | $10K |
| Atorvastatin Calcium | 671 | $9,686 |
| Flecainide Acetate | 100 | $7,925 |
| Clopidogrel Bisulfate | 442 | $6,486 |
| Carvedilol | 561 | $6,218 |
Prescribing Profile
56
Unique Drugs
$952K
Patient Profile
76
Avg Age
48%
Female
1.50
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data